/RPID

RPID Stock - Rapid Micro Biosystems, Inc.

Q: What is the analyst price target for RPID?

Analyst price target information is not currently available for RPID.

Q: What is RPID's market cap?

Market capitalization information is not currently available for RPID.

Healthcare|Medical - Devices|NASDAQ

$3.15-5.69%

$0.19 (-5.69%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

100

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+154.0%upside

Target: $8.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for RPID

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta1.34

52W High$4.50

52W Low$0.87

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$28.05M	$22.52M	$17.13M	$23.23M	$16.08M
Gross Profit	$-109,000	$-5,485,000	$-8,540,000	$-7,741,000	$-8,071,000
Gross Margin	-0.4%	-24.4%	-49.8%	-33.3%	-50.2%
Operating Income	$-49,919,000	$-56,563,000	$-63,219,000	$-47,232,000	$-30,540,000
Net Income	$-46,889,000	$-52,467,000	$-60,806,000	$-73,524,000	$-37,078,000
Net Margin	-167.2%	-233.0%	-354.9%	-316.5%	-230.6%
EPS	$-1.08	$-1.22	$-1.43	$-1.88	$-1.17

Company Overview

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides installation and verification, technical training, and support services. Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications. The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.

Visit Website

Rating Distribution

Strong Buy

Buy / Outperform

50%

Hold / Neutral

50%

Sell / Underperform

Analyst Consensus🟡 Mixed

1 Bullish1 Neutral/Bearish

Price Targets

Average Target

↑ 154.0% Upside

Now

Low

Average

High

Based on 2 analysts

Recent Analyst Actions

Date	Firm	Action	Rating	Price Target
July 28th 2025	Lake Street	Initiation	Buy	$8
February 12th 2025	KeyBanc Capital Markets	Initiation	Overweight	$8
August 16th 2022	JP Morgan	Downgrade	Neutral	-

Earnings History & Surprises

RPID

Beat Rate

33%

Last 18 quarters

Avg Surprise

-264.3%

EPS vs Estimate

Beats / Misses

6/9

3 met exactly

Latest EPS

$-0.26

Q4 2025

EPS Surprise History

Q1 24

+16.1%

$-0.26vs$-0.31

Q2 24

-6.9%

$-0.31vs$-0.29

Q3 24

-3.6%

$-0.29vs$-0.28

Q4 24

0.0%

$-0.26vs$-0.26

Q1 25

0.0%

$-0.22vs$-0.22

Q2 25

+3.7%

$-0.26vs$-0.27

Q3 25

-3.8%

$-0.27vs$-0.26

Q4 25

0.0%

$-0.26vs$-0.26

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q2 2026	May 7, 2026	—	—	—	—
Q1 2026	Feb 27, 2026	$-0.23	—	—	—
Q4 2025	Nov 7, 2025	$-0.26	$-0.26	0.0%	= MET
Q3 2025	Aug 12, 2025	$-0.26	$-0.27	-3.8%	✗ MISS
Q2 2025	May 9, 2025	$-0.27	$-0.26	+3.7%	✓ BEAT
Q1 2025	Feb 28, 2025	$-0.22	$-0.22	0.0%	= MET
Q4 2024	Nov 1, 2024	$-0.26	$-0.26	0.0%	= MET
Q3 2024	Aug 2, 2024	$-0.28	$-0.29	-3.6%	✗ MISS
Q2 2024	May 3, 2024	$-0.29	$-0.31	-6.9%	✗ MISS
Q1 2024	Mar 1, 2024	$-0.31	$-0.26	+16.1%	✓ BEAT
Q4 2023	Nov 3, 2023	$-0.32	$-0.31	+3.1%	✓ BEAT
Q3 2023	Aug 4, 2023	$-0.36	$-0.33	+8.3%	✓ BEAT
Q2 2023	May 5, 2023	$-0.36	$-0.32	+11.1%	✓ BEAT
Q1 2023	Mar 3, 2023	$-0.38	$-0.39	-2.6%	✗ MISS
Q4 2022	Nov 10, 2022	$-0.37	$-0.38	-2.7%	✗ MISS
Q3 2022	Aug 12, 2022	$-0.35	$-0.31	+11.4%	✓ BEAT
Q2 2022	May 10, 2022	$-0.33	$-0.35	-6.1%	✗ MISS
Q1 2022	Mar 4, 2022	$-0.34	$-0.35	-2.9%	✗ MISS
Q4 2021	Nov 11, 2021	$-0.38	$-0.39	-2.6%	✗ MISS
Q3 2021	Aug 26, 2021	$-0.41	$-20.01	-4780.5%	✗ MISS

Frequently Asked Questions about RPID

What is RPID's current stock price?

Rapid Micro Biosystems, Inc. (RPID) is currently trading at $3.15 per share. The stock has moved -5.69% today.

What is the analyst price target for RPID?

The average analyst price target for RPID is $8.00, based on 1 analyst.

What sector is Rapid Micro Biosystems, Inc. in?

Rapid Micro Biosystems, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.

What is RPID's market cap?

Rapid Micro Biosystems, Inc. has a market capitalization of $0.14 billion, making it a small-cap company.

Does RPID pay dividends?

No, Rapid Micro Biosystems, Inc. does not currently pay a dividend to shareholders.